Skip to content

Combined rTMS and Relaxation in Chronic Tinnitus

Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) in Combination With Relaxation Therapy in Patients With Chronic Tinnitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01907022
Acronym
RELAX
Enrollment
42
Registered
2013-07-24
Start date
2013-07-31
Completion date
2014-10-31
Last updated
2015-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Tinnitus

Keywords

repetitive transcranial magnetic stimulation, chronic tinnitus, relaxation

Brief summary

Repetitive Transcranial Magnetic Stimulation in combination with relaxation therapy is used to modulate the neural pathways contributing to the perception and distress of phantom sounds.

Detailed description

Tinnitus is the phantom auditory perception of sound in the absence of an external or internal acoustic stimulus. It is a frequent problem which can interfere significantly with the ability to lead a normal life. One significant modulator of tinnitus is stress. Tinnitus has been shown to be generated in the brain, as a result of functional reorganization of auditory neural pathways and the central auditory system. Also non-auditory cortical areas of attention allocation and emotional processing was shown to be involved. Treatment remains difficult. The most effective treatment in chronic tinnitus is cognitive behavioral therapy including elements of relaxation therapy. Repetitive transcranial magnetic stimulation (rTMS) is also effective in treatment of tinnitus with moderate effect size. Pilot data were positive for low-frequency rTMS applied to the temporoparietal areas and high-frequency rTMS applied to the left frontal cortex. Newer findings indicate that exercise-combined non-invasive brain stimulation might show superior effects in contrast to rTMS or exercise alone. Combination of relaxation and two-sided (frontal and temporo-parietal) rTMS will be examined with regard to feasibility, safety and clinical efficacy in patients suffering from chronic tinnitus in a pilot trial.

Interventions

High frequency rTMS ( Alpine Biomed Mag Pro Option): 2000 stimuli of 20 Hz over the left DLPFC (each session), Butterfly-water-cooled-Coil, 110% motor threshold; followed by: low frequency rTMS ( Alpine Biomed Mag Pro Option) applied over left temporoparietal cortex, Butterfly-water-cooled-Coil (2000 Stimuli of 1 Hz each session), 110% motor threshold. Relaxation therapy during the 1Hz stimulation with external audio tape instructions. Arms: Left DLPFC Butterfly Coil

Sponsors

University of Regensburg
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of bothersome, subjective chronic tinnitus * Duration of tinnitus more than 6 months

Exclusion criteria

* Objective tinnitus * Treatable cause of the tinnitus * Involvement in other treatments for tinnitus at the same time * Clinically relevant psychiatric comorbidity * Clinically relevant unstable internal or neurological comorbidity * History of or evidence of significant brain malformation or neoplasm, head injury * Cerebral vascular events * Neurodegenerative disorder affecting the brain or prior brain surgery * Metal objects in and around body that can not be removed * Pregnancy * Alcohol or drug abuse * Prior treatment with TMS

Design outcomes

Primary

MeasureTime frame
Number of treatment responders (TQ reduction > 5, contrast Baseline versus end of treatment)Week 12

Secondary

MeasureTime frame
Change of tinnitus severity as measured by the Tinnitus Handicap Inventory (THI)Week 4
Change of tinnitus severity as measured by the Tinnitus Severity ScaleWeek 4
Change of tinnitus severity as measured by the Tinnitus Questionaire of Goebel&HillerWeek 4
Change in quality of life as measured by the World Health Organization Quality of Life (WHOQoL)Week 2
Change in quality of life as measured by the World Health Organization Quality of Life(WHOQoL)Week 4
Change of depressive symptoms as measured by the Major Depression Inventory (MDI)Week 4

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026